A critical discovery in cancer study is occurring with the use of VHH fragments to reactivate mutated p53. This essential cancer protector protein is frequently disabled in several types of tumors, resulting https://getsocialnetwork.com/story7543808/vhh-fragments-reactivate-tumor-suppressor-p53-a-promising-hope-for-cancer-therapy